Altrova Health (FRA:WF8) ROE % Adjusted to Book Value: -39.21% (As of Mar. 2026)


What is Altrova Health ROE % Adjusted to Book Value?

Altrova Health FRA:WF8 ROE % Adjusted to Book Value is -39.21% as of Mar. 2026. The stock has 3 warning signs investors should review.

Altrova Health's ROE % for the quarter that ended in Mar. 2026 was -117.63%. Altrova Health's PB Ratio for the quarter that ended in Mar. 2026 was 3.00. Altrova Health's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 was -39.21%.


Altrova Health ROE % Adjusted to Book Value Related Terms


Altrova Health ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for Altrova Health's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Altrova Health ROE % Adjusted to Book Value Chart

Altrova Health Annual Data
Trend Sep23 Sep24 Sep25
ROE % Adjusted to Book Value
0.00 -56.28 -107.47

Altrova Health Quarterly Data
Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only -42.13 -13.65 -113.16 -28.06 -39.21

FRA:WF8 vs BLK, BX, KKR: ROE % Adjusted to Book Value Comparison

For the Asset Management subindustry, Altrova Health's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Altrova Health ROE % Adjusted to Book Value vs Asset Management Industry

For the Asset Management industry and Financial Services sector, Altrova Health's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Altrova Health's ROE % Adjusted to Book Value falls into.



Altrova Health ROE % Adjusted to Book Value Calculation

Altrova Health's ROE % Adjusted to Book Value for the fiscal year that ended in Sep. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-309.52% / 2.88
=-107.47%

Altrova Health's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-117.63% / 3.00
=-39.21%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of -39.21% mean?
Altrova Health (FRA:WF8) has a ROE % Adjusted to Book Value of -39.21% as of Mar. 2026. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Altrova Health and its competitors.
Is Altrova Health's ROE % Adjusted to Book Value too high?
Altrova Health's current ROE % Adjusted to Book Value is -39.21%.
How does Altrova Health's ROE % Adjusted to Book Value compare to BLK and BX?
Altrova Health's ROE % Adjusted to Book Value of -39.21% can be compared against companies in the Asset Management industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for an Asset Management company?
A good ROE % Adjusted to Book Value depends on the Asset Management industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Altrova Health and its competitors. Altrova Health's current ROE % Adjusted to Book Value is -39.21%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Altrova Health stock overvalued right now?
Altrova Health (FRA:WF8) has a current ROE % Adjusted to Book Value of -39.21%. The current ROE % Adjusted to Book Value is -39.21%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Altrova Health (FRA:WF8), the current ROE % Adjusted to Book Value is -39.21% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Altrova Health Business Description

Other Exchanges SSPLF:USAROVA:Canada
Address 666 Burrard Street, 25th Floor, Vancouver, BC, CAN, V6C 2X8
Altrova Health Inc is a Canadian public company building a growing portfolio of health solutions across detection, protection, treatment, and wellness. The Company is focused on supporting multiple products, brands, and growth pathways under one stronger corporate identity, expanding beyond any single product story to create a more durable business. The Company continues to evaluate opportunities to expand its product offerings across the public health and safety sector.